404 related articles for article (PubMed ID: 20479417)
21. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG
Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568
[TBL] [Abstract][Full Text] [Related]
22. "Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study.
Brown HG; Kepner JL; Perlman EJ; Friedman HS; Strother DR; Duffner PK; Kun LE; Goldthwaite PT; Burger PC
J Neuropathol Exp Neurol; 2000 Oct; 59(10):857-65. PubMed ID: 11079775
[TBL] [Abstract][Full Text] [Related]
23. Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction.
Morowitz M; Shusterman S; Mosse Y; Hii G; Winter CL; Khazi D; Wang Q; King R; Maris JM
Mod Pathol; 2003 Dec; 16(12):1248-56. PubMed ID: 14681326
[TBL] [Abstract][Full Text] [Related]
24. [Detection of chromosomal DNA imbalance in medulloblastoma by comparative genomic hybridization].
Sun YJ; Yu SZ; Sun CY; Wang Q; Jin SM; Wu WX; An TL
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):606-10. PubMed ID: 21092588
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort.
Pietsch T; Schmidt R; Remke M; Korshunov A; Hovestadt V; Jones DT; Felsberg J; Kaulich K; Goschzik T; Kool M; Northcott PA; von Hoff K; von Bueren AO; Friedrich C; Mynarek M; Skladny H; Fleischhack G; Taylor MD; Cremer F; Lichter P; Faldum A; Reifenberger G; Rutkowski S; Pfister SM
Acta Neuropathol; 2014 Jul; 128(1):137-49. PubMed ID: 24791927
[TBL] [Abstract][Full Text] [Related]
26. Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours.
Goschzik T; Zur Mühlen A; Kristiansen G; Haberler C; Stefanits H; Friedrich C; von Hoff K; Rutkowski S; Pfister SM; Pietsch T
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):135-44. PubMed ID: 24894640
[TBL] [Abstract][Full Text] [Related]
27. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
[TBL] [Abstract][Full Text] [Related]
28. Loss of 10q26.1-q26.3 in association with 7q34-q36.3 gain or 17q24.3-q25.3 gain predict poor outcome in pediatric medulloblastoma.
Pezzolo A; Coco S; Raso A; Parodi F; Pistorio A; Valdora F; Capra V; Zollo M; Aschero S; Basso E; Cama A; Nozza P; Gambini C; Cinalli G; Garrè ML; Iolascon A; Pistoia V; Tonini GP
Cancer Lett; 2011 Sep; 308(2):215-24. PubMed ID: 21652146
[TBL] [Abstract][Full Text] [Related]
29. Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas.
Lo KC; Rossi MR; Burkhardt T; Pomeroy SL; Cowell JK
Genes Chromosomes Cancer; 2007 Jan; 46(1):53-66. PubMed ID: 17044047
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
31. MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma.
Ryan SL; Schwalbe EC; Cole M; Lu Y; Lusher ME; Megahed H; O'Toole K; Nicholson SL; Bognar L; Garami M; Hauser P; Korshunov A; Pfister SM; Williamson D; Taylor RE; Ellison DW; Bailey S; Clifford SC
Acta Neuropathol; 2012 Apr; 123(4):501-13. PubMed ID: 22139329
[TBL] [Abstract][Full Text] [Related]
32. Novel amplifications in pediatric medulloblastoma identified by genome-wide copy number profiling.
Nord H; Pfeifer S; Nilsson P; Sandgren J; Popova S; Strömberg B; Alafuzoff I; Nistér M; Díaz de Ståhl T
J Neurooncol; 2012 Mar; 107(1):37-49. PubMed ID: 21979893
[TBL] [Abstract][Full Text] [Related]
33. Metaphase and array comparative genomic hybridization: unique copy number changes and gene amplification of medulloblastomas in South America.
Yoshimoto M; Bayani J; Nuin PA; Silva NS; Cavalheiro S; Stavale JN; Andrade JA; Zielenska M; Squire JA; de Toledo SR
Cancer Genet Cytogenet; 2006 Oct; 170(1):40-7. PubMed ID: 16965953
[TBL] [Abstract][Full Text] [Related]
34. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
Lo KC; Ma C; Bundy BN; Pomeroy SL; Eberhart CG; Cowell JK
Clin Cancer Res; 2007 Dec; 13(23):7022-8. PubMed ID: 18056178
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies.
Schwalbe EC; Williamson D; Lindsey JC; Hamilton D; Ryan SL; Megahed H; Garami M; Hauser P; Dembowska-Baginska B; Perek D; Northcott PA; Taylor MD; Taylor RE; Ellison DW; Bailey S; Clifford SC
Acta Neuropathol; 2013 Mar; 125(3):359-71. PubMed ID: 23291781
[TBL] [Abstract][Full Text] [Related]
36. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
[TBL] [Abstract][Full Text] [Related]
37. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
[TBL] [Abstract][Full Text] [Related]
38. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.
Chen QR; Bilke S; Wei JS; Whiteford CC; Cenacchi N; Krasnoselsky AL; Greer BT; Son CG; Westermann F; Berthold F; Schwab M; Catchpoole D; Khan J
BMC Genomics; 2004 Sep; 5():70. PubMed ID: 15380028
[TBL] [Abstract][Full Text] [Related]
39. [Clinicopathologic significance of β-catenin protein and loss of heterozygosity on 10q in medulloblastoma].
Li JZ; Wang CH; Zhou FA; Miao N; Abulajang G; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):823-7. PubMed ID: 23324231
[TBL] [Abstract][Full Text] [Related]
40. Genome wide copy number abnormalities in pediatric medulloblastomas as assessed by array comparative genome hybridization.
Lo KC; Rossi MR; Eberhart CG; Cowell JK
Brain Pathol; 2007 Jul; 17(3):282-96. PubMed ID: 17465989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]